Boticarium III

• Autores: Juan Medrano Albéniz
• Localización: Revista de la Asociación Española de Neuropsiquiatría, ISSN 0211-5735, Vol. 32, Nº. 115, 2012, págs. 619-631
• Idioma: español
• DOI: 10.4321/s0211-57352012000300013
• Enlaces
  • Texto completo
• Referencias bibliográficas
  • (1) Food and Drug Administration. Clozaril (clozapine) Tablets. Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation...
  • (2) Chennattucherry JJ, Currie A, Piracha I. Tardive dyskinesia: psychiatrists’ knowledge and practice. The Psychiatrist 2011, 35:164-7. Accesible...
  • (3) American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association...
  • (4) Rodríguez-Artalejo F, Baca E, Esmatjes E, Merino-Torres JF, Monereo S, Moreno B, et al. Valoración y control del riesgo metabólico y cardiovascular...
  • (5) Bainbridge E, Gallagher A, McDonald G, McDonald C, Ahmed M. General practitioners’ attitudes on who should manage metabolic dysregulations...
  • (6) Jones PB, Barnes TR, Davies L, Dunn G, Lloyd H, Hayhurst KP, et al. Randomized controlled trial of the effect on Quality of Life of secondvs...
  • (7) Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Effectiveness of antipsychotic drugs in patients with...
  • (8) Bernardo M, Coma A, Ibañez C, Zara C, Bari JM, Serrano-Blanco A. Antipsychotic polypharmacy in a regional health service: a population-based...
  • (9) Huys D, Hardenacke K, Poppe P, Bartsch C, Baskin B, Kuhn J. Update on the role of antipsychotics in the treatment of Tourette syndrome....
  • (10) Nuevos datos de seguridad sobre los antipsicóticos Olanzapina y Risperidona en el tratamiento de pacientes ancianos con Psicosis o Trastornos...
  • (11) NOTA INFORMATIVA (Ref: 2008/19) de 28 de noviembre de 2008: Anti- psicóticos clásicos y aumento de mortalidad en pacientes ancianos con...
  • (12) Huybrechts KF, Schneeweiss S, Gerhard T, Olfson M, Avorn J, Levin R, et al. Comparative safety of antipsychotic medications in nursing...
  • (13) Sinclair L. Antipsychotics for Elderly Vary in Mortality Risk. Psychiatric News 2012; 47(9): 22-3. Accesible en: http:// psychnews.psychiatryonline.org/newsArticle.aspx?articleid=1130402
  • (14) Huybrechts KF, Schneeweiss S, Gerhard T, Olfson M, Avorn J, Levin R, et al. Comparative safety of antipsychotic medications in nursing...
  • (15) Alzheimer’s Society. Optimi- sing treatment and care for people with beha- vioural and psychological symptoms of dementia: A best practice...
  • (16) Turner EH, Knoepflmacher D, Shapley L (2012) Publication Bias in Antipsychotic Trials: An Analysis of Efficacy Comparing the Published...
  • (17) Agencia Española de Medicamentos y Productos Sanitarios. Escitalopram: Prolongación del intervalo QT del electrocardiograma. 2 de diciembre...
  • (18) Zyban (bupropion hydrochloride) Prescribing Information January 2012. Accesible en: http://www.accessdata.fda.gov/ drugsatfda_docs/label/2012/020711s036lbl....
  • (19) Labos C, Dasgupta K, Nedjar H, Turecki G, Rahme E. Risk of bleeding asso- ciated with combined use of selective serotonin reuptake inhibitors...
  • (20) Taylor C. What is the antide- pressant of choice in coronary heart disea- se? London: London Medicines Information Service. Accesible...
  • (21) Gibbons RD, Hur K, Brown CH, Davis JM, Mann JJ. Benefits From Antidepressants: Synthesis of 6-Week Patient-Level Outcomes From Double-blind...
  • (22) Kirsch I, Deacon BJ, HuedoMedina TB, Scoboria A, Moore TJ, et al. (2008) Initial Severity and Antidepressant Benefits: A Meta-Analysis...
  • (23) Moran M. New Data Rebut Claims About Antidepressants. Psychiatric News 2012; 47 (8): 12a-12a. Accesible en: http://psychnews.psychiatryonline.org/...
  • (24) Rothschild AJ. Do Antidepressants Cause Suicide? Psychiatric News 2012; 47 (1): 17b-17b. Accesible en: http://psychnews.psychiatryonline.org/newsArticle....
  • (25) Guaiana G, Andretta M, Griez E, Biancosino B, Grassi L. Sales of antidepressants, suicides and hospital admissions for depression in...
  • (26) Pompili M, Goldblatt MJ. Psychopharmacological Treatment to Reduce Suicide Risk. A Brief Review of Available Medications. Psychiatric...
  • (27) AEMPS. Antiepilépticos y riesgo de alteraciones óseas. Informe mensual medicamentos de uso humano. Octubre 2011. Accesible en: http://www.aemps.gob....
  • (28) García C. Abbott pagará en EE UU una multa de 1.600 millones de dólares por fraude. El País, 8 de mayo de 2012. Accesible en: http://sociedad....
  • (29) Occhiogrosso M, Omran SS, Altemus M. Persistent pulmonary hypertension of the newborn and selective serotonin reuptake inhibitors: lessons...
  • (30) Food and Drug Administra- tion. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants: Drug Safety Communication Use During Pregnancy...
  • (31) El Marroun H, Jaddoe VWV, Hudziak JJ, Roza SJ, Steegers EAP, Hofman A, et al. Maternal Use of Selective Serotonin Reuptake Inhibitors,...
  • (32) Agencia Española de Medicamentos y Productos Sanitarios. Noviembre 2011. Medicamentos de uso humano. Accesible en: http://www.aemps.gob.es/informa/...
  • (33) Scottish Intercollegiate Guideline Network. SIGN guideline: Management of perinatal mood disorders. 22/03/2012. Accesible en: http://www.nelm.nhs.uk/en/...
  • (34) MHRA. Drug safety update: Atomoxetine (Strattera): increases in blood pressure and heart rate—new contraindications, warnings, and advice...
  • (35) Agencia Española de Medicamentos y Productos Sanitarios. Atomoxetina (Strattera®) y aumento de la presión arterial y frecuencia cardíaca:...
  • (36) Schelleman H, Bilker WB, Kimmel SE, Daniel GW, Newcomb C, Guevara JP, et al. Methylphenidate and risk of serious cardiovascular events...
  • (37) Moran M. Stimulants & Cardiovascular Safety: Risk-Benefit Issues Get Clearer. Psychiatric News 2012; 47 (7): 16b-16b. Accesible en:...
  • (38) Habel LA, Cooper WO, Sox CM, Chan KA, Fireman BH, Arbogast PG, et al ADHD medications and risk of serious cardiovascular events in young...
  • (39) Brooks M. New Evidence Addresses ADHD Meds and Adult CVD Risk. Medscape Psychiatry & Mental Health. Accesible en: http://www.medscape.com/view...
  • (40) Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, et al. ADHD drugs and serious cardiovascular events in children and young...
  • (41) Moran M. More Research Needed on SSRIs for Treating Autism Disorders. Psychiatric News 2012; 47 (11): 11a-11a. Accesible en: http://psychnews.psychiatryonline.org/newsArticle.aspx?articleid=1170362
  • (42) Carrasco M, Volkmar FR, Bloch MH. Pharmacologic Treatment of Repetitive Behaviors in Autism Spectrum Disorders: Evidence of Publication...
  • (43) Andrade SE, Lo JC, Roblin D, Fouayzi H, Connor DF, Penfold RB, Chandra M, Reed G, Gurwitz JH. Antipsychotic medication use among children...
  • (44) Sinclair L. Inconsistent Data Link Antipsychotic Use, Diabetes. Psychiatric News 2012; 47 (2): 22a-22a. Accesible en: http://psychnews.psychiatryonline.org/...
  • (45) Drury SC, Gleason MM. A Delicate Brain: Ethical and Practical Considerations for the Use of Medications in Very Young Children. Psychiatric...
  • (46) Food and Drug Administration. Chantix (varenicline) Tablets 0.5 mg and 1 mg. Safety Labeling Changes Approved By FDA Center for Drug...
  • (47) Prochaska JJ, Hilton JF. Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic...
  • (48) Moore TJ, Furberg CD, Glenmullen J, Maltsberger JT, Singh S (2011) Suicidal Behavior and Depression in Smoking Cessation Treatments....
  • (49) Shekhar A, Potter WZ, Lightfoot J, Lienemann J, Dubé S, Mallinckrodt C, Bymaster FP, McKinzie DL, Felder CC. Selective muscarinic receptor...
  • (50) Freedman R, Olincy A, Buchanan RW, Harris JG, Gold JM, Johnson L, et al. Initial phase 2 trial of a nicotinic agonist in schizophrenia....
  • (51) Hong LE, Thaker GK, McMa- hon RP, Summerfelt A, Rachbeisel J, Fuller RL, et al. Effects of moderate-dose treatment with varenicline on...
  • (52) Snyder BD, Polasek TM, Doogue MD. Drug interactions: principles and practice. Australian Prescriber 2012; 35 (3). Accesible en: http://www.australianprescriber.com/magazine/35/3/85/8
  • (53) Leucht S, Hierl S, Kissling W, Dold M, Davis JM. Putting the efficacy of psychiatric and general medicine medication into perspective:...
  • (54) Moran M. Psychiatric Drugs’ Efficacy on Par With Those for Other Disorders. Psychiatric News 2012; 47 (9): 1b-28. Accesible en: http://psychnews.psychiatryonline.org/newsArticle....
  • (55) Seemüller F, Möller HJ, Dittmann S, Musil R. Is the efficacy of psychopharmacological drugs comparable to the efficacy of general medicine...
  • (56) Boussageon R, Supper I, Bejan-Angoulvant T, Kellou N, Cucherat M, et al. (2012). Reappraisal of Metformin Efficacy in the Treatment of...